GlassScriptPhysician profile
Scott W Burk
NPI 1538271465
$1,449.08
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $215 · 2021: $94.89 · 2022: $48.18 · 2023: $36.55 · 2024: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $186.61 | 2019-2024 | Gardasil 9, Gardasil, Vaxelis |
| Glaxosmithkline, LLC. | $161.11 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $139.77 | 2019-2021 | |
| Pfizer INC. | $115.79 | 2019 | |
| Novo Nordisk INC | $112.33 | 2019-2024 | Ozempic, Rybelsus |
| Amgen INC. | $80.19 | 2019-2021 | |
| Abbvie INC. | $77.61 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $77.53 | 2019-2020 | |
| Lilly USA, LLC | $71.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $64.75 | 2019-2020 | |
| Exact Sciences Corporation | $51.06 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $49.75 | 2019 | |
| Mylan Specialty L.P. | $44.41 | 2019 | |
| Sanofi Pasteur INC. | $32.55 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $31.63 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $29.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.27 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.09 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.87 | 2020 | |
| Dexcom, INC. | $20.33 | 2023 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $15.97 | 2021 | |
| Acorda Therapeutics, INC | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Burk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.